image
Healthcare - Medical - Devices - NASDAQ - US
$ 0.9901
2.07 %
$ 76.7 M
Market Cap
-1.74
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one HYPR stock under the worst case scenario is HIDDEN Compared to the current market price of 0.99 USD, Hyperfine, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one HYPR stock under the base case scenario is HIDDEN Compared to the current market price of 0.99 USD, Hyperfine, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one HYPR stock under the best case scenario is HIDDEN Compared to the current market price of 0.99 USD, Hyperfine, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
11 M REVENUE
61.90%
-48.1 M OPERATING INCOME
34.87%
-44.2 M NET INCOME
39.54%
-41.8 M OPERATING CASH FLOW
42.20%
-804 K INVESTING CASH FLOW
-37.44%
174 K FINANCING CASH FLOW
2385.71%
3.64 M REVENUE
0.33%
-11 M OPERATING INCOME
-1.08%
-10.3 M NET INCOME
-1.67%
-8.52 M OPERATING CASH FLOW
9.23%
-159 K INVESTING CASH FLOW
-123.94%
851 K FINANCING CASH FLOW
1342.37%
Balance Sheet Hyperfine, Inc.
image
Current Assets 88.9 M
Cash & Short-Term Investments 75.2 M
Receivables 4.13 M
Other Current Assets 9.59 M
Non-Current Assets 5.29 M
Long-Term Investments 0
PP&E 3 M
Other Non-Current Assets 2.29 M
Current Liabilities 8.77 M
Accounts Payable 1.21 M
Short-Term Debt 185 K
Other Current Liabilities 7.37 M
Non-Current Liabilities 1.03 M
Long-Term Debt 0
Other Non-Current Liabilities 1.03 M
EFFICIENCY
Earnings Waterfall Hyperfine, Inc.
image
Revenue 11 M
Cost Of Revenue 6.28 M
Gross Profit 4.76 M
Operating Expenses 52.9 M
Operating Income -48.1 M
Other Expenses -3.88 M
Net Income -44.2 M
RATIOS
43.12% GROSS MARGIN
43.12%
-436.14% OPERATING MARGIN
-436.14%
-401.00% NET MARGIN
-401.00%
-52.42% ROE
-52.42%
-46.96% ROA
-46.96%
-56.20% ROIC
-56.20%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Hyperfine, Inc.
image
Net Income -44.2 M
Depreciation & Amortization 1.05 M
Capital Expenditures -804 K
Stock-Based Compensation 4.74 M
Change in Working Capital -3.62 M
Others -116 K
Free Cash Flow -42.6 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Hyperfine, Inc.
image
Wall Street analysts predict an average 1-year price target for HYPR of $1.6 , with forecasts ranging from a low of $1.6 to a high of $1.6 .
HYPR Lowest Price Target Wall Street Target
1.6 USD 61.60%
HYPR Average Price Target Wall Street Target
1.6 USD 61.60%
HYPR Highest Price Target Wall Street Target
1.6 USD 61.60%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Hyperfine, Inc.
image
Sold
0-3 MONTHS
7.38 K USD 1
3-6 MONTHS
2.38 K USD 1
6-9 MONTHS
2.88 K USD 1
9-12 MONTHS
2.42 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 week ago
Feb 20, 2025
Sell 3.5 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 3238
1.08 USD
1 week ago
Feb 18, 2025
Sell 3.88 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 3237
1.2 USD
3 months ago
Nov 18, 2024
Sell 2.38 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 2800
0.85 USD
6 months ago
Aug 16, 2024
Sell 2.88 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 2746
1.05 USD
9 months ago
May 16, 2024
Sell 2.42 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 2753
0.88 USD
1 year ago
Feb 16, 2024
Sell 3.59 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 3230
1.11 USD
1 year ago
Nov 16, 2023
Sell 3.35 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 2655
1.26 USD
1 year ago
Aug 16, 2023
Sell 6.29 K USD
TEISSEYRE THOMAS
Chief Operating Officer
- 2785
2.26 USD
1 year ago
Aug 16, 2023
Sell 3.91 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 1729
2.26 USD
1 year ago
May 16, 2023
Sell 2.17 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 1735
1.25 USD
2 years ago
Feb 16, 2023
Sell 6.44 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 4635
1.39 USD
2 years ago
Feb 16, 2023
Sell 7.8 K USD
Gupta Alok
Chief Financial Officer
- 5613
1.39 USD
3 years ago
Feb 03, 2022
Bought 87.8 K USD
HC Sponsor LLC
Director
+ 21947
4 USD
3 years ago
Jan 26, 2022
Bought 292 K USD
HC Sponsor LLC
Director
+ 78053
3.747 USD
3 years ago
Jan 21, 2022
Bought 113 K USD
HC Sponsor LLC
Director
+ 25000
4.502 USD
3 years ago
Jan 12, 2022
Bought 55.2 K USD
HC Sponsor LLC
Director
+ 8410
6.569 USD
3 years ago
Jan 11, 2022
Bought 19.6 K USD
HC Sponsor LLC
Director
+ 2913
6.728 USD
3 years ago
Jan 10, 2022
Bought 91.6 K USD
HC Sponsor LLC
Director
+ 13677
6.698 USD
3 years ago
Dec 29, 2021
Bought 700 K USD
HC Sponsor LLC
Director
+ 100000
7 USD
2 years ago
Dec 14, 2022
Bought 4.75 K USD
Sainz Maria
President and CEO
+ 5000
0.95 USD
2 years ago
Dec 09, 2022
Bought 10.6 K USD
Sainz Maria
President and CEO
+ 12425
0.85 USD
2 years ago
Dec 08, 2022
Bought 2.14 K USD
Sainz Maria
President and CEO
+ 2575
0.83 USD
2 years ago
Nov 30, 2022
Bought 188 K USD
ROTHBERG JONATHAN M
Director
+ 229215
0.82 USD
2 years ago
Nov 29, 2022
Bought 33.8 K USD
ROTHBERG JONATHAN M
Director
+ 47007
0.72 USD
2 years ago
Nov 16, 2022
Sell 87.3 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 1039
84 USD
2 years ago
Nov 16, 2022
Sell 1.59 K USD
Paykel Neela
Gen Counsel & Corp Secretary
- 1895
0.84 USD
2 years ago
Nov 16, 2022
Sell 1.87 K USD
Gupta Alok
Chief Financial Officer
- 2227
0.84 USD
2 years ago
Nov 15, 2022
Bought 28.6 K USD
ROTHBERG JONATHAN M
Director
+ 31139
0.92 USD
2 years ago
Nov 14, 2022
Bought 30.7 K USD
ROTHBERG JONATHAN M
Director
+ 34488
0.89 USD
2 years ago
Aug 15, 2022
Sell 1.5 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 1035
1.45 USD
2 years ago
Aug 15, 2022
Sell 12.9 K USD
Gupta Alok
Chief Financial Officer
- 8871
1.45 USD
2 years ago
Aug 15, 2022
Sell 2.74 K USD
Paykel Neela
Gen Counsel & Corp Secretary
- 1891
1.45 USD
2 years ago
Aug 16, 2022
Bought 95.2 K USD
ROTHBERG JONATHAN M
director:
+ 64213
1.482 USD
2 years ago
Aug 12, 2022
Bought 442 K USD
ROTHBERG JONATHAN M
director:
+ 303137
1.457 USD
2 years ago
Jul 05, 2022
Sell 9.79 K USD
Siddiqui Khan
CMO and Chief Strategy Officer
- 4846
2.02 USD
2 years ago
Jul 05, 2022
Sell 21.3 K USD
Paykel Neela
Gen Counsel & Corp Secretary
- 10542
2.02 USD
2 years ago
Jun 14, 2022
Bought 119 K USD
ROTHBERG JONATHAN M
director:
+ 52848
2.26 USD
20 years ago
Sep 21, 2004
Bought 3.53 K USD
SLEPICKA KENNETH J
Director
+ 1000
3.53 USD
7. News
Hyperfine Announces $6.0 Million Registered Direct Offering GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company's Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warrant were sold together at a combined offering price of $1.33 in a registered direct offering. The warrants have an e. businesswire.com - 2 weeks ago
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis. businesswire.com - 3 weeks ago
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans. businesswire.com - 2 months ago
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting. businesswire.com - 2 months ago
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon. seekingalpha.com - 3 months ago
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. zacks.com - 3 months ago
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update. globenewswire.com - 3 months ago
Hyperfine Announces European Launch with CE Approval GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation. businesswire.com - 3 months ago
HYPR Achieves Positive Swoop System Data for ECMO: Stock to Rise? Hyperfine announces a publication on using the Swoop system for patients on ECMO support. The study showed the safety of using an ultra-low-field portable brain MRI on patients undergoing ECMO. zacks.com - 5 months ago
Favorable Data on Swoop Portable MRI Likely to Support Hyperfine Stock Compared to conventional MRI, which takes an average of 27.7 hours, the Swoop system of HYPR operates with a median time-to-scan of 2.5 hours. zacks.com - 5 months ago
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care PARIS--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced the presentation of interim data supporting the role portable ultra-low-field MRI can play in acute stroke workup in a hospital emergency department setting. The findings from the study, titled Interim Analysis from Single Centre Observational Study. businesswire.com - 5 months ago
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission. Researchers will utilize the Swoop® Portable MR Imaging® system at a SpaceX facility in. businesswire.com - 5 months ago
8. Profile Summary

Hyperfine, Inc. HYPR

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 76.7 M
Dividend Yield 0.00%
Description Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
Contact 351 New Whitfield Street, Guilford, CT, 06437 https://hyperfine.io
IPO Date Jan. 28, 2021
Employees 131
Officers Dr. Jonathan M. Rothberg Ph.D. Founder & Vice Chairman Mr. Edmond Knopp M.D. Chief Medical Officer Dave Castiglioni Chief Commercial Officer Mr. Brett Hale Chief Administrative Officer, Chief Financial Officer, Chief Compliance Officer, Treasurer & Corporate Secretary Dr. Thomas Teisseyre Ph.D. Chief Operating Officer Mr. R. Scott Huennekens CPA, M.B.A. Executive Chairman Ms. Maria Sainz Chief Executive Officer, President & Director